Parabilis Medicines, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $148 | $0 | $0 | $0 |
Gross Profit | 148 | -618 | ||
EBITDA | -51,660 | -44,418 | -35,902 | -37,273 |
EBIT | -52,253 | -45,024 | -36,520 | -37,927 |
Net Income | -52,463 | -45,316 | -34,810 | -38,326 |
Net Change In Cash | 148 | 0 | 0 | 0 |
Free Cash Flow | -4,238 | -49,569 | -31,105 | -34,228 |
Cash | 1,087,060 | 329,039 | ||
Basic Shares | 28,908 | 2,050 | 2,019 | 2,017 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -141,867 | -114,328 |
EBIT | -144,367 | -116,428 |
Net Income | -145,889 | -117,914 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -124,019 | -104,492 |
Cash | 27,711 | 47,284 |
Basic Shares | 2,023 | 1,934 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$2.13 |